This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_THYROID_MEDULLARY_EXALLC for full statistics.
Medullary carcinoma of thyroid gland
C3_THYROID_MEDULLARY
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
31 |
4. Check minimum number of eventsNone |
31 |
5. Include endpointsNone |
31 |
6. Filter based on genotype QC (FinnGen only) |
31 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Medullary carcinoma of thyroid gland
based on the number of shared cases.
Similar with more cases:
- Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of thyroid gland
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 31 | 24 | 7 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 40.06 | 42.84 | 30.52 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
24
0
+∞
30.21
9.1
0.0
pmol/l
227.8
—
—
13
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
5
42.66
10.90
4.5
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
0
+∞
8.72
3.3
0.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
24
114
5.86
4.59
9.0
5.2
mmol/l
1.2
1.2
0.50
24
103
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
8
8.94
3.21
2.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
0
57
0.00
2.37
0.0
1.3
—
14.8
—
0
23
(3000494) Fungus identified in Specimen by Culture
0
36
0.00
1.23
0.0
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
11
64
2.11
1.03
2.3
10.5
—
—
—
0
0
(4035726)
6
30
2.23
0.93
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
14
188
0.53
0.86
2.9
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
5
92
0.46
0.84
1.2
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
8
52
1.72
0.66
1.8
2.4
—
—
—
0
0
(3015736) pH of Urine
7
109
0.54
0.63
2.9
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
20
0.00
0.63
0.0
1.5
—
—
—
0
0
(3000492) Spirometry study
0
22
0.00
0.62
0.0
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
10
71
1.60
0.46
1.7
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5
34
1.56
0.42
1.4
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.42
0.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
75
0.60
0.42
1.6
2.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
17
0.00
0.42
0.0
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
17
0.00
0.42
0.0
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
21
235
0.67
0.36
16.0
15.5
%
43.2
40.0
2.18
16
162
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
14
116
1.38
0.29
4.3
3.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
8
99
0.74
0.26
2.1
2.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
5
39
1.34
0.24
3.8
3.7
umol/l
5.6
8.4
—
5
33
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
26
269
0.79
0.23
13.6
14.6
mg/l
26.4
25.0
0.06
19
204
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
42
1.23
0.22
1.2
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
11
0.00
0.22
0.0
2.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
10
0.00
0.22
0.0
3.0
—
0.8
—
0
10
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
10
0.00
0.22
0.0
3.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
13
0.00
0.21
0.0
4.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.8
—
162.8
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
153.1
—
0
13
(3000330) Specific gravity of Urine by Test strip
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
67
1.26
0.19
2.0
4.9
—
—
—
0
0
(3044889) 12 lead EKG panel
21
192
1.29
0.18
4.0
3.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
9
78
1.22
0.18
4.1
2.8
ng/l
735.1
738.5
—
9
67
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
106
0.79
0.16
2.7
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
5
47
1.08
0.10
1.8
2.0
nmol/l
1198.6
1457.6
—
5
31
(3023368) Bacteria identified in Blood by Culture
6
70
0.82
0.08
2.3
4.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
8
72
1.15
0.08
1.9
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
7
81
0.83
0.08
1.9
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
12
114
1.09
0.01
2.4
2.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
14
145
0.94
0.00
2.9
2.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
15
153
0.96
0.00
8.4
7.1
umol/l
9.7
9.9
0.04
15
139
(1761868) Lipid panel - Serum or Plasma
10
99
1.01
0.00
2.8
3.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
17
171
0.99
0.00
2.9
3.1
u/l
82.3
61.2
0.18
17
156
(42870588) Differential panel, method unspecified - Blood
8
82
0.97
0.00
2.8
5.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
0.2
—
0
7
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.3
—
0.0
—
0
8
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.3
—
0.0
—
0
8
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.2
—
0.5
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
6.3
—
0
5
(3027315) Oxygen [Partial pressure] in Blood
0
7
0.00
0.00
0.0
4.7
—
7.5
—
0
7
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
80.9
—
0
9
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.3
—
35.0
—
0
8
(3027008) Opiates [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
7
0.00
0.00
0.0
1.0
—
1.1
—
0
7
(1616796) Gas panel - Central venous blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013512) EKG study
8
84
0.94
0.00
5.4
3.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
1.3
—
0
5
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
134.0
—
0
6
(3013290) Carbon dioxide [Partial pressure] in Blood
0
7
0.00
0.00
0.0
4.7
—
5.2
—
0
7
(3014051) Protein [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.4
—
0
7
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036489) Thrombin time
0
6
0.00
0.00
0.0
1.3
—
19.2
—
0
6
(3050129) First trimester maternal screen panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
0
5
0.00
0.00
0.0
3.6
—
11.6
—
0
5
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.2
—
0.0
—
0
9
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.5
—
45.8
—
0
6
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
5
0.00
0.00
0.0
3.6
—
108.2
—
0
5
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.3
—
0.0
—
0
8
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
5
0.00
0.00
0.0
1.2
—
91.8
—
0
5
(3023419) Bacteria identified in Sputum by Culture
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_THYROID_MEDULLARY – Medullary carcinoma of thyroid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).